Searched for
HEPARIN INJECTIONS
Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...- Pakistan: Severe shortage of life-saving drugs in Karachi worries patients, citizensKarachi in Pakistan is facing a severe shortage of essential medicines, including life-saving drugs, causing concern for patients and citiz...
- Next big delta in pharma to come from biosimilars: Nithya Balasubramanian“For Aurobindo Pharma, our official rating is market performance. We do not recommend it from a long-term perspective. It is only a tactica...
- Morgan Stanley offloads stake in this pharma stock via bulk dealMorgan Stanley Investment Funds Emerging Markets Equity Fund has sold a 0.58% stake in Gland Pharma via open market transactions. The sell-...
- Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...
- Low-cost blood thinning drug may potentially treat, prevent COVID-19: StudyThe initial results from 98 patients, published in the British Journal of Clinical Pharmacology, indicate that heparin could be a promising...
- ICMR national protocol says no evidence of benefit of injectable steroids in patients not requiring oxygenThe revised guidance updated on January 14 also warns of potential risk of fungal infections such as invasive mucormycosis, if anti-inflamm...
- Covid-19: Key drugs, steroids in short supply; input costs surgeTwo anti-virals — Remdesivir and Favipiravir — and Tocilizumab injections being used in the Covid-19 treatment have witnessed massive short...
- Prices of medicines to go up a tad; companies seek 20% jumpPrices of essential medicines including painkillers, antiinfectives, cardiac and antibiotics could go up marginally from April, with the go...
- Ceiling prices of heparin injection allowed upward revision till March 2021: Gowda"Heparin injection has been included in the COVID-19 protocol list of essential medicines for patients admitted in ICU due to COVID-19, cir...
- Lack of clarity on Covid vaccines' safety may derail India's next phase of inoculationThis could mean a large section of the people with comorbidities such as diabetes, hypertension and heart disease — who are among the prior...
- Bengaluru doctor with double kidney transplant takes jab, backs itDr AP Nirmal Raj pointed out he took the Covid vaccine on January 17. “I’m taking anti-diabetic, cholesterol drugs and have undergone angio...
- Can you get Covid-19 & dengue at the same time? Experts say it's possible, treatment can be complicatedFor a treating doctor it is like 'walking a tight rope'.
- Covid-19, dengue double infection treatment complicated; needs balanced approach: ExpertsDelhi Deputy Chief Minister Manish Sisodia was shifted to LNJP Hospital on Wednesday for COVID-19 treatment and tested positive for dengue ...
- Telangana to conduct 40,000 coronavirus tests daily, keep beds ready all over stateThe Cabinet also decided to act stringently against private hospitals, which were indulging in irregularities while giving treatment to the...
- Drug makers get nod to raise one-time price increase on heparin injectionsThe NPPA has allowed for upward revision of heparin injection 1000IU/ ml and heparin injection 5000IU/ ml under para 19 of DPCO 2013 by 50%...
- Torrent, Dr Reddy’s, Aurobindo, Cipla, Lupin in race to buy SagentValuation is expected to be upwards of $500 million (Rs 3,400 crore), for which large generic drug makers and financial investors like glob...
- Gland Pharma promoters put their 60 per cent stake on the blockPromoters of Hyderabad-based speciality injectable drugs maker Gland Pharma have decided to put their controlling stake on the block.
- KKR set to pick up 35% stake in Gland Pharma for about Rs 1,300 croreThe two-part transaction, likely to be announced this week, is a combination of fresh equity infusion and a buyout of Evolvance India Life ...
- Venus: Phase IV of Baddi projectVenus Remedies has completed Phase IV of the Baddi project comprising two dedicated plants for specialty formulations.
Load More
